Trial Profile
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 19 Jul 2023
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Fish oil
- Indications Breast cancer
- Focus Pharmacodynamics
- 13 Jul 2023 Status changed from recruiting to completed.
- 25 Aug 2022 Planned primary completion date changed from 1 Jun 2022 to 1 Jun 2023.
- 26 Jul 2021 Planned End Date changed from 1 Jun 2022 to 1 Jun 2024.